SPARC and keloid: Our findings verified that SPARC could activate p38γ pathway to stabilize the expression of 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 (PFKFB3), and thus participate in the glycolysis of keloid fibroblasts and the progression of keloid.